Skip to content

Datenblatt ansehen

open_in_new
  1. Alles ansehen
  2. Recombinant Proteins

PME100981

Human MMP2 Protein; His Tag

Größe

£219.00

SKU:
PME100981
Zusätzliche Namen:
CLG4;CLG4A;MMP-2;MMP-II;MONA;TBE-1
Molekulargewicht:
The protein has a predicted molecular mass of 71.8 kDa after removal of the signal peptide.The apparent molecular mass of MMP2-His is approximately 55-70 kDa due to glycosylation.
Reinheit:
The purity of the protein is greater than 85% as determined by SDS-PAGE and Coomassie blue staining.
Lagerbedingungen:
Store at -20[o]C to -80[o]C for 12 months in lyophilized form. After reconstitution; if not intended for use within a month; aliquot and store at -80[o]C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
Hersteller:
DIMA Biotechnology Ltd
Formulierung:
Lyophilized from sterile PBS; pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Target:
MMP2
MMP2(Ala30-Cys660) 6×His tag:
MMP2(Ala30-Cys660) 6×His tag
Weitere Details:
This gene is a member of the matrix metalloproteinase (MMP) gene family; that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A; type IV collagenase; that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members; activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases; or; intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system; endometrial menstrual breakdown; regulation of vascularization; and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq; Oct 2014]
Versandbedingungen:
Ambient